Background: Aim of the study was to evaluate the diagnostic performance of FDG PET-CT for the detection of local and distant disease relapse in surgically treated patients with renal cell carcinoma (RCC).
Material And Methods: This retrospective study includes 96 patients underwent FDG PET-CT scanning in the post-surgical follow up within the first 6-12 months referred to nuclear medicine department, to perform PET/CT study. Each patient underwent FDG PET-CT with low dose CT, followed immediately by full dose Ce-CT.